Overexpression of metastasis-associated protein 1 (MTA1) has been observed in many human malignancies and is significantly related to tumor invasion and metastasis, therapeutic resistance to radiation and chemotherapy, making MTA1 an ideal candidate tumor antigen. We identified several human leukocyte antigen- (HLA-) A2-restricted epitopes in MTA1 and evaluated their binding ability to HLA-A0201 molecules. Subsequently, a recombinant fragment encompassing the dominant epitopes, MTA1, was expressed, and the abilities of the selected epitopes of MTA1 and the MTA1 fragment to induce cytotoxic T lymphocytes (CTLs) were examined. Our results indicated that the epitopes and MTA1 fragment elicited HLA-A2-restricted and antigen-specific CTL responses both and . The new epitopes identified here may help promote the development of new therapeutic vaccines for HLA-A2 patients expressing MTA1.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286779PMC
http://dx.doi.org/10.1155/2018/2942679DOI Listing

Publication Analysis

Top Keywords

epitopes mta1
16
mta1
9
epitopes identified
8
mta1 fragment
8
epitopes
5
hla-a2-restricted epitopes
4
identified mta1
4
mta1 elicit
4
elicit antigen-specific
4
antigen-specific cytotoxic
4

Similar Publications

The NuRD chromatin remodeling and deacetylation complex, which includes MTA1, MBD3, CHD4, and HDAC1 among other components, is of importance for development and cancer progression. The oncogenic mucin 1 (MUC1) C-terminal subunit (MUC1-C) protein activates EZH2 and BMI1 in the epigenetic reprogramming of triple-negative breast cancer (TNBC). However, there is no known link between MUC1-C and chromatin remodeling complexes.

View Article and Find Full Text PDF

Overexpression of metastasis-associated protein 1 (MTA1) has been observed in many human malignancies and is significantly related to tumor invasion and metastasis, therapeutic resistance to radiation and chemotherapy, making MTA1 an ideal candidate tumor antigen. We identified several human leukocyte antigen- (HLA-) A2-restricted epitopes in MTA1 and evaluated their binding ability to HLA-A0201 molecules. Subsequently, a recombinant fragment encompassing the dominant epitopes, MTA1, was expressed, and the abilities of the selected epitopes of MTA1 and the MTA1 fragment to induce cytotoxic T lymphocytes (CTLs) were examined.

View Article and Find Full Text PDF

Constructing Chimeric Antigen for Precise Screening of HTLV-I Infection.

Iran J Allergy Asthma Immunol

August 2015

Department of Biotechnology, Faculty of Medical Science, Tarbiat Modares University, Tehran, Iran.

Individual preparation of two human T-cell lymphotropic virus type I (HTLV-I) diagnostic GST fused peptides (MTA-1 and GD21) is time-consuming and expensive. The aim of this study was to design a novel single chimeric antigen (SCA) to obviate separate expression of proteins and reduce the cost of reagent preparation. Structural protein fragments, including immunodominant B cell linear epitopes, were selected and different SCAs were designed.

View Article and Find Full Text PDF

Truncated MTA-1: a pitfall in ELISA-based immunoassay of HTLV-1 infection.

J Biomed Biotechnol

July 2008

Division of Human Genetics, Immunology Research Center, Bu-Ali Research Institute, Bu-Ali square, Mashhad 9196773117, Iran.

HTLV-1 causes adult T-cell leukemia (ATL) and HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). Recombinant envelope glycoprotein is used in production of diagnostic enzyme-linked immunosorbent assay (ELISA) kit. There are some reports that a significant percentage of Iranian HTLV-1 infected patients showed no seroreactivity with MTA-1 peptide, while HTLV-1 had been confirmed by PCR detection methods or ELISA kits containing a cocktail of HTLV-1 specific peptides.

View Article and Find Full Text PDF

STLV-1 viruses are closely related to HTLV-1 and infect many African monkey species. Seroreactivities of monkeys infected by STLV-1 are nearly identical to those of HTLV-1-infected individuals. In some cases, STLV-1 are, sequence-wise, indistinguishable from HTLV-1, and cannot be separated from them on the basis of phylogenetic analyses.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!